drugset / Trial / NCT05901467

Recall by Genotype: Neuropeptide Stimulation

NCT05901467 ↗

Phase 1 Terminated 16 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelOther

Summary

The objective of this protocol is to assess response to kisspeptin and gonadotropin-releasing hormone (GnRH) stimulation testing as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals who carry variants in genes related to infertility.

Timeline

Start
2023-10-20
Primary completion
2024-05-29
Completion
2024-05-29

Outcome

Outcome not reported

Stopped: “The study team no longer has access to GnRH. The study has been altered to account for this change and is no longer a clinical trial.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic — Intravenous
Subject kisspeptin 112-121 Peptide — Intravenous